Piperacillin/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection

Abstract

Piperacillin/tazobactam (PTZ) is frequently used in patients with diabetic foot infections. Herein, we report a patient who developed severe neutropenia, thrombocytopenia, and fever while receiving PTZ for a diabetic foot infection. We recommend vigilance when long-term PTZ use is planned in patients with diabetic foot infections.

Keywords::

• Antimicrobials
• adverse effect
• diabetic foot
• neutropenia

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.